| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| EP-114 | Human | TSLP[Biotinylated]:IL-7Rα & TSLP R Inhibitor Screening ELISA Kit |
|
||
| TSP-R52H3 | Rat | Rat TSLP Protein, His Tag |  |
|
|
| TSP-C82E3 | Cynomolgus | Biotinylated Cynomolgus TSLP Protein, His,Avitag™ |  |
|
|
| TSP-M82E3 | Mouse | Biotinylated Mouse TSLP Protein, His,Avitag™ |  |
|
|
| TSP-C52H8 | Cynomolgus | Cynomolgus TSLP Protein, His Tag |  |
|
|
| TSP-C52H4 | Cynomolgus | Cynomolgus TSLP (R127A, R130S) Protein, His Tag |  |
|
|
| TSP-M52H8 | Mouse | Mouse TSLP Protein, His Tag |  |
|
|
| TSP-H5255 | Human | Human TSLP (R127A, R130A) Protein, Mouse IgG2a Fc Tag |  |
|
|
| TSP-H82E0 | Human | Biotinylated Human TSLP (R127A, R130A) Protein, His,Avitag™ (MALS verified) |  |
|
|
| TSP-H52Ha | Human | Human TSLP (R127A, R130A) Protein, His Tag (MALS verified) |  |
|
|
| TSP-H52Hb | Human | Human TSLP Protein, His Tag |  |
|
|
| TSP-H82Eb | Human | Biotinylated Human TSLP Protein, His,Avitag™ |  |
|
|
Captured Human TSLP (R127A, R130A), His Tag (Cat. No. TSP-H52Ha) on CM5 Chip via anti-His antibody, can bind Human TSLP R, Fc Tag (Cat. No. TSR-H525a) with an affinity constant of 4.22 nM as determined in SPR assay (Biacore T200) (Routinely tested).
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Tezepelumab | MEDI-9929; AMG-157 | Approved | Amgen Inc | Tezspire | United States | Asthma | Astrazeneca Ab | 2021-12-17 | Lung Diseases, Obstructive; Nasal Polyps; Chronic Urticaria; Nose Diseases; Lung Diseases; Sinusitis; Asthma; Respiratory Hypersensitivity; Hypersensitivity, Immediate; Bronchial Diseases; Pulmonary Disease, Chronic Obstructive; Dermatitis, Atopic; Hypersensitivity | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| BSI-045B | BSI-045B | Phase 1 Clinical | Boaoxin Biotechnology(Nanjing) Co Ltd | Dermatitis, Atopic | Details |
| SHR-1905 | SHR-1905 | Phase 1 Clinical | Shanghai Hengrui Pharmaceutical Co Ltd | Asthma | Details |
| GR-1802 | GR-1802 | Phase 2 Clinical | Zhixiang (Shanghai) Pharmaceutical Technology Co Ltd | Asthma; Sinusitis; Dermatitis, Atopic | Details |
| CSJ-117 | CSJ-117; NOV-14 | Phase 2 Clinical | Novartis Pharma Ag | Asthma; Pulmonary Disease, Chronic Obstructive | Details |
| CM-326(Connaught Biomedical Technology) | CM-326 | Phase 2 Clinical | Keymed Biosciences Co Ltd | Nasal Polyps; Sinusitis; Asthma; Pulmonary Disease, Chronic Obstructive; Dermatitis, Atopic | Details |
This web search service is supported by Google Inc.
A-Z
